PGL prospa group limited.

lung cancer trial fails

  1. 498 Posts.
    This company is now a one-trick pony, with superior drugs like Nexavar showing greater efficacy over a much wider range of conditions.

    Most analysts are rating this one a strong sell.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.